Stephanie E Combs
Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
Rogers S, Lux S, Maier S, Minasch D, Rezazadeh A, Steffal C, Temming S, Wittig A, Zweifel C, Riesterer O, Lohaus F, Henke G, Hemmatazad H, Baumert B, Blanck O, Böhmer D, Boström J, Engenhart-Cabillic R, Ermiş E, Exner S, Guckenberger M, Habermehl D, Combs S. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO). Strahlenther Onkol 2022; 198:919-925.
Aug 25, 2022Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
Aug 25, 2022Strahlenther Onkol 2022; 198:919-925
Rogers Susanne, Lux S, Maier S E, Minasch D, Rezazadeh A, Steffal C, Temming S, Wittig A, Zweifel C, Riesterer O, Lohaus Fabian, Henke Guido, Hemmatazad H, Baumert B, Blanck O, Böhmer Dirk, Boström J, Engenhart-Cabillic R, Ermiş Ekin, Exner S, Guckenberger M, Habermehl D, Combs Stephanie E
Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis
Kroeze S, Schymalla M, Abbasi-Senger N, Buergy D, Geier M, Szuecs M, Lohaus F, Henke G, Combs S, Stera S, Adebahr S, Sundahl N, Fritz C, Schaule J, Blanck O, Kahl K, Kaul D, Siva S, Gerum S, Claes A, Guckenberger M. Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis. Cancers (Basel) 2021; 13
Sep 24, 2021Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis
Sep 24, 2021Cancers (Basel) 2021; 13
Kroeze Stephanie G C, Schymalla Markus M, Abbasi-Senger Nasrin, Buergy Daniel, Geier Michael, Szuecs Marcella, Lohaus Fabian, Henke Guido, Combs Stephanie E, Stera Susanne, Adebahr Sonja, Sundahl Nora, Fritz Corinna, Schaule Jana, Blanck Oliver, Kahl Klaus Henning, Kaul David, Siva Shankar, Gerum Sabine, Claes An, Guckenberger Matthias
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Schaule J, Lohaus F, Abbasi-Senger N, Henke G, Szuecs M, Geier M, Sundahl N, Buergy D, Dummer R, Eckert F, Adebahr S, Schymalla M, Kroeze S, Blanck O, Stera S, Kahl K, Roeder F, Combs S, Kaul D, Claes A, Guckenberger M. Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score. Radiat Oncol 2020; 15:280.
Dec 14, 2020Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Dec 14, 2020Radiat Oncol 2020; 15:280
Schaule Jana, Lohaus Fabian, Abbasi-Senger Nasrin, Henke Guido, Szuecs Marcella, Geier Michael, Sundahl Nora, Buergy Daniel, Dummer Reinhard, Eckert Franziska, Adebahr Sonja, Schymalla Markus M, Kroeze Stephanie G C, Blanck Oliver, Stera Susanne, Kahl Klaus H, Roeder Falk, Combs Stephanie E, Kaul David, Claes An, Guckenberger Matthias
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Schaule J, Lohaus F, Abbasi-Senger N, Henke G, Szuecs M, Geier M, Sundahl N, Buergy D, Dummer R, Eckert F, Adebahr S, Schymalla M, Kroeze S, Blanck O, Stera S, Kahl K, Roeder F, Combs S, Kaul D, Claes A, Guckenberger M. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score. Radiat Oncol 2020; 15:135.
Jun 1, 2020Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Jun 1, 2020Radiat Oncol 2020; 15:135
Schaule Jana, Lohaus Fabian, Abbasi-Senger Nasrin, Henke Guido, Szuecs Marcella, Geier Michael, Sundahl Nora, Buergy Daniel, Dummer Reinhard, Eckert Franziska, Adebahr Sonja, Schymalla Markus M, Kroeze Stephanie G C, Blanck Oliver, Stera Susanne, Kahl Klaus H, Roeder Falk, Combs Stephanie E, Kaul David, Claes An, Guckenberger Matthias
Evaluation of radiation-related invasion in primary patient-derived glioma cells and validation with established cell lines: impact of different radiation qualities with differing LET.
Wank M, Schilling D, Reindl J, Meyer B, Gempt J, Motov S, Alexander F, Wilkens J, Schlegel J, Schmid T, Combs S. Evaluation of radiation-related invasion in primary patient-derived glioma cells and validation with established cell lines: impact of different radiation qualities with differing LET. J Neurooncol 2018; 139:583-590.
Jun 8, 2018Evaluation of radiation-related invasion in primary patient-derived glioma cells and validation with established cell lines: impact of different radiation qualities with differing LET.
Jun 8, 2018J Neurooncol 2018; 139:583-590
Wank M, Schilling D, Reindl J, Meyer Benedikt J, Gempt Jens, Motov Stefan, Alexander F, Wilkens J J, Schlegel Jürgen, Schmid T, Combs Stephanie E
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Beier D, Proescholdt M, Reinert C, Pietsch T, Jones D, Pfister S, Hattingen E, Seidel C, Dirven L, Luerding R, Reijneveld J, Warmuth-Metz M, Bonsanto M, Bremer M, Combs S, Rieken S, Herrlinger U, Kuntze H, Mayer-Steinacker R, Moskopp D, Schneider T, Beringer A, Schlegel U, Stummer W, Welker H, Weyerbrock A, Paulsen F, Rutkowski S, Weller M, Wick W, Kortmann R, Bogdahn U, Hau P. Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro Oncol 2018; 20:400-410.
Feb 19, 2018Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Feb 19, 2018Neuro Oncol 2018; 20:400-410
Beier Dagmar, Proescholdt Martin, Reinert Christiane, Pietsch Torsten, Jones David T W, Pfister Stefan M, Hattingen Elke, Seidel Clemens, Dirven Linda, Luerding Ralf, Reijneveld Jaap, Warmuth-Metz Monika, Bonsanto Matteo, Bremer Michael, Combs Stephanie E, Rieken Stefan, Herrlinger Ulrich, Kuntze Holger, Mayer-Steinacker Regine, Moskopp Dag, Schneider Thomas, Beringer Andreas, Schlegel Uwe, Stummer Walter, Welker Helmut, Weyerbrock Astrid, Paulsen Frank, Rutkowski Stefan, Weller Michael, Wick Wolfgang, Kortmann Rolf-Dieter, Bogdahn Ulrich, Hau Peter
Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-margins (PREMISS)
Röper B, von Eisenharth-Rothe R, Kampfer S, Molls M, Toepfer A, Wörtler K, Specht K, Rechl H, Kehl V, Heinrich C, Combs S. Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-margins (PREMISS). BMC cancer 2015; 15:904.
Nov 16, 2015Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-margins (PREMISS)
Nov 16, 2015BMC cancer 2015; 15:904
Röper Barbara, von Eisenharth-Rothe Rüdiger, Kampfer Severin, Molls Michael, Toepfer Andreas, Wörtler Klaus, Specht Katja, Rechl Hans, Kehl Victoria, Heinrich Christine, Combs Stephanie E